The effect of angiotensin-converting enzyme inhibitors on human neutrophil chemotaxis in vitro.

1. Myocardial 'reperfusion injury' has been partly attributed to the production of free radicals which are cytotoxic towards cells. Neutrophils are recruited by ischaemic tissue and are one source of free radicals. Angiotensin-converting enzyme (ACE) inhibitors can reduce 'reperfusion injury' and we decided to determine if ACE inhibitors might contribute to this effect by inhibiting neutrophil chemotaxis. 2. The effects of captopril (a thiol containing ACE inhibitor) and enalaprilat (a nonthiol ACE inhibitor) and N-mercaptopropionyl glycine (MPG) (a simple thiol) on neutrophil chemotaxis were tested in an in vitro Boyden chamber assay. 3. The chemotactic response of human neutrophils to fMLP was reduced by 27.6% with MPG (n = 8; P < 0.05), by 13.2% with enalaprilat (n = 8; P = 0.075) and by 5.2% with captopril (n = 8; P = 0.66) at 5 microM (therapeutic concentration.) 4. Neutrophil chemotaxis was significantly decreased with 50 microM and 500 microM MPG and enalaprilat and 500 microM captopril. 5. Supratherapeutic concentrations of ACE inhibitors can reduce neutrophil chemotaxis at high concentrations and this effect does not appear to be -SH dependent.
AuthorsM Clapperton, J McMurray, A C Fisher, H J Dargie
JournalBritish journal of clinical pharmacology (Br J Clin Pharmacol) Vol. 38 Issue 1 Pg. 53-6 (Jul 1994) ISSN: 0306-5251 [Print] ENGLAND
PMID7946937 (Publication Type: Journal Article)
Chemical References
  • N-Formylmethionine Leucyl-Phenylalanine
  • Captopril
  • Tiopronin
  • Enalaprilat
  • Captopril (pharmacology)
  • Cell Migration Inhibition
  • Chemotaxis, Leukocyte (drug effects)
  • Enalaprilat (pharmacology)
  • Female
  • Humans
  • In Vitro Techniques
  • Male
  • Middle Aged
  • N-Formylmethionine Leucyl-Phenylalanine (pharmacology)
  • Neutrophils (drug effects)
  • Tiopronin (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: